TNF and endothelial dysfunction: The current conventional drugs for RA treatment, including glucocorticoids [24] and etanercept (a TNF-α inhibitor) [9], have been demonstrated to improve endothelial dysfunction through the anti-inflammatory effect in RA rat models.